Viewing nowElpas Tablets (L-Carnitine)
L-Carnitine 330mg
Tablet · OTC medication
Ilhwa Co., Ltd.

MFDS item code 202204012 · Notified 2022.11.04
Treatment of carnitine deficiency and myocardial metabolic disorders due to ischemic heart disease
This medication is used for primary and secondary carnitine deficiency and myocardial metabolic disorders caused by ischemic heart disease, such as angina and acute myocardial infarction.
Adults: Administer (take) 2-3g of L-carnitine orally in 2-3 divided doses daily. Adjust the dose as appropriate according to age and symptoms.
This medication should not be used in patients who have allergic reactions to it. During use, temporary symptoms such as nausea, vomiting, abdominal pain, diarrhea, and body odor may occur. Additionally, there have been reports of skin rash or hives, and facial swelling, so if these symptoms appear, immediate consultation with a healthcare professional is necessary. Patients with impaired kidney function may experience mild muscle weakness, so caution is needed. Pregnant women or women who may become pregnant should only take this medication when the benefits of treatment outweigh the risks, as its safety has not been fully confirmed. Furthermore, it is unclear how much of this medication is transmitted through breast milk, but many drugs can be passed to the baby through breast milk, so it should be used with caution while breastfeeding.
Not everyone experiences these, and they can vary from person to person.
This medication should be used in consultation with a doctor or pharmacist when administered with other injectable lipid preparations.
This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is advisable to maintain the storage temperature between 1 and 30 degrees Celsius at room temperature. Proper storage will help maintain the medication’s effectiveness and safety.
White round film-coated tablets
90 tablets/box [(10 tablets/PTP*9)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowL-Carnitine 330mg
Tablet · OTC medication
Ilhwa Co., Ltd.
L-Carnitine 200mg
Prescription medication
Albozen Korea Co., Ltd.

L-Carnitine 330mg
Tablet · OTC medication
Seoul Pharmaceutical Co., Ltd.
L-Carnitine 330mg
Tablet · OTC medication
HLB Pharmaceuticals Co., Ltd.

L-Carnitine 330mg
Tablet · OTC medication
Daehan New Pharm Co., Ltd.

L-Carnitine 330mg
Tablet · OTC medication
Gyeongnam Pharmaceutical Co., Ltd.

L-Carnitine 330mg
Tablet · OTC medication
SS Pharm Co., Ltd.

L-Carnitine 330mg
Tablet · OTC medication
Mothers Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
QIn what situations is this medication taken?
Answers 1 · 2026.09.14
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.